DuboisE. L.: Corticosteroid-Induced Peptic Ulcer—A Serial Roentgenological Survey of Patients Receiving High Dosages, Am. J. Gastroenterol.33: 435 (Apr.) 1960.
2.
RothJ.: Role of Drugs in Production of Gastroduodenal Ulcer, J. Am. Med. Assoc.187: 418 (Feb. 8) 1964.
3.
LipsonJ.: Adrenal Steroids and Ulcer Formation, Ann. Allergy22: 89 (Feb.) 1964.
4.
MelbyJ.: Adrenocorticosteroids in Medical Emergencies, Med. Clin. N. Am.45: 875 (July) 1961.
5.
CassL. J.: Complications of Corticotropin Therapy in Multiple Sclerosis, J. Am. Med. Assoc.197: 173 (July 18) 1966.
6.
LeonardsJ.LevyG.: Biopharmaceutical Aspects of Aspirin-Induced Gastrointestinal Blood Loss in Man, J. Pharm. Sci.58: 1277 (Oct.) 1969.
7.
LeonardsJ.LevyG.: Reduction or Prevention of Aspirin-Induced Occult Gastrointestinal Blood Loss in Man, Clin. Pharmacol. Therap.10: 571 (July-Aug.) 1969.
8.
MenguyR.MastersY.: Effects of Aspirin on Gastric Mucous Secretion, Surg. Gynecol. Obstet.120: 92 (Jan.) 1965.
9.
DavenportH.: Gastric Mucosal Injury by Fatty and Acetylsalicylic Acids, Gastroenterology46: 245, 1964.
10.
DavenportH.: Damage to the Gastric Mucosa—Effects of Salicylates and Stimulation, ibid.49: 189 (Aug.) 1965.
11.
DavenportH.: Fluid Produced by the Gastric Mucosa During Damage by Acetic and Salicylic Acids, ibid.50: 487 (Apr.) 1966.
12.
DavenportH.: Salicylate Damage to the Gastric Mucosal Barrier, New Engl. J. Med.276: 1307 (June 8) 1967.
13.
BrodieD.ChaseB.: Role of Gastric Acid in Aspirin-induced Gastric Irritation in the Rat, Gastroenterology, 53: 604, 1967.
14.
DouthwaiteH.LintottA.: Gastroscopic Observation of the Effect of Aspirin and Certain Other Substances on the Stomach, Lancet2: 1222 (Nov. 26) 1938.
AlvarezD.SummerskillJ.: Gastrointestinal Hemorrhages and Salicylates, Lancet2: 92 (Nov. 1) 1958.
17.
ScottJ.: Studies of Gastrointestinal Bleeding Caused by Corticosteroids, Salicylates, and Other Analgesics, Quart. J. Med.30: 167 (Apr.) 1961.
18.
WeissA.: Aspirin and Gastric Bleeding, Am. J. Med.31: 266 (Aug.) 1961.
19.
VickersF.StanleyL.: Gastroduodenoscopic Observations, Four Case Reports, Gastroenterology44: 419 (Apr.) 1963.
20.
Cheng-SingS.: Cyclophosphamide in the Treatment of Systemic Lupus Erythematosus, Brit. Med. J.1: 333 (Feb. 5) 1966.
21.
FreckmanH.: Chemotherapy for Lung Cancer by Intra-Aortic Infusion, J. Am. Med. Assoc.196: 5 (Apr. 4) 1966.
22.
MengelC.: Malignant Carcinoid-Effect of Parenteral Methotrexate Therapy Alone and in Combination with Cyclophosphamide Orally, Cancer Chemotherapy Repts.51: 239 (Aug.) 1967.
23.
LieglerD.: The Effect of Organic Acids on Renal Clearance of Methotrexate in Man, Clin. Pharmacol. Therap.10: 849 (Nov.-Dec.) 1969.
24.
MertzD.PoppeW.: Magensaftsekretion unter der Wirkung von Furosemid, Klin. Wochschr.46: 820–823 (Aug. 1) 1968.
25.
PainA.: Acute Gastric Ulceration Associated with Drug Therapy, New Engl. J. Med.276: 634 (Mar. 11) 1967.